# Adaptimmune Therapeutics PLC: Form 8-K, filed Jun 5, 2017

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2017-06-05
- Accepted by EDGAR: Jun 5, 2017, 10:28 ET
- Period: 2017-06-05
- Accession: 0001104659-17-037379
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465917037379/a17-14214_38k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465917037379/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465917037379/a17-14214_38k.htm

Filed Jun 5, 2017.
Source: SEC EDGAR, the filing index for accession 0001104659-17-037379. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
